‘Avobenzone is protected,’ says toxicology evaluation

The findings, printed this month in Vital Opinions in Toxicology, arrive at a crucial time for North American producers, suppliers, and regulatory stakeholders because the FDA continues its ongoing overview of sunscreen elements.

“For manufacturers and formulators, this overview additional validates avobenzone’s function as a cornerstone of broad-spectrum UV safety,” Dr. Kimberly Norman, PCPC’s senior director of security and regulatory toxicology and lead creator on the research, informed CosmeticsDesign.

Examine confirms low absorption & no important toxicity markers

The overview assessed each scientific and nonclinical information to judge avobenzone’s human well being threat profile, masking pharmacokinetics, toxicology, and real-world publicity information from human biomonitoring and regulatory databases.

The authors concluded that “avobenzone has an acceptable security profile with none clear markers of toxicity or endpoints of concern.” They discovered “no proof of avobenzone results on immune tissues or the estrogen, androgen, or thyroid methods,” and famous that the ingredient “has not proven any indication of genotoxicity both in vitro or in vivo.”

Importantly for formulators and regulatory affairs groups, dermal absorption was discovered to be low. “The scientific information point out very low percutaneous absorption in people,” at lower than 1% of the utilized dose, the authors wrote.

The overview established a NOAEL (no-observed-adverse-effect stage) of 450 mg/kg/day from sub-chronic oral research in rats, leading to a calculated margin of security larger than 100, which exceeds the usual thresholds for security assurance.

Findings supply readability for business and regulators

The Private Care Merchandise Council (PCPC), which sponsored the analysis, emphasised the importance of the findings for the U.S. market.

“The findings of the excellent overview reinforce what a long time of scientific information have already proven: avobenzone is a protected and efficient sunscreen ingredient,” stated Dr. Norman.

“At a time when customers are more and more scrutinizing product security and producers are navigating evolving regulatory landscapes, the findings present readability and reassurance.”

For North American producers and suppliers, the overview helps continued innovation inside regulatory parameters. “Customers, producers, suppliers and different stakeholders needs to be assured within the findings of this overview,” Dr. Norman stated.

Formulation implications & and the FDA overview course of

In the US, avobenzone is permitted to be used in OTC sunscreen merchandise at concentrations as much as 3%. It’s at present the one FDA-listed devoted UVA absorber within the Sunscreen Monograph, making it a foundational part of broad-spectrum solar care merchandise in the marketplace.

“This complete, weight-of-evidence analysis is supportive of the continued protected use of avobenzone,” Dr. Norman stated. “It reaffirms the protected use of the UV filter inside regulatory security necessities.”

The overview may additionally assist information the FDA’s ongoing overview of sunscreen energetic elements. “The overview supplies strong, science-based proof that helps its continued protected use,” she stated. “We hope that the analysis informs FDA’s selections by reinforcing the ingredient’s security profile and guiding future regulatory updates by means of balancing innovation with client safety.”

A possible mannequin for future ingredient critiques

The research’s methodology, which includes each conventional and non-animal testing information, could function a framework for evaluating different UV filters at present below regulatory scrutiny.

“Sure, this overview units a robust precedent for a way UV filters and different sunscreen elements might be assessed utilizing present scientific methodologies, together with non-animal testing strategies, and clear processes,” Dr. Norman stated.

She added {that a} related strategy was used for one more current security analysis of sunscreen ingredient ensulizole, highlighting the business’s dedication to proactive ingredient overview.

Supply: Vital Opinions in Toxicology, 55(6), 662–692. doi: 10.1080/10408444.2025.2535394. “Complete overview of avobenzone (butyl methoxydibenzoylmethane) toxicology information and human publicity evaluation for private care merchandise.” Authors: Norman, Okay. G., et al.